|
|
Volumn 28, Issue 10, 2010, Pages 992-993
|
|
Roche backs Aileron's stapled peptides
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKENE;
BH3 PROTEIN;
NUCLEIC ACID;
PEPTIDE;
PROTEIN;
PROTEIN BAD;
PROTEIN BCL 2;
STAPLED PEPTIDE;
UNCLASSIFIED DRUG;
APOPTOSIS;
CELL MEMBRANE PERMEABILITY;
CELL SURVIVAL;
DRUG INDUSTRY;
HUMAN;
INSULIN RELEASE;
NOTE;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
PROTEIN FUNCTION;
TUMOR XENOGRAFT;
CLINICAL TRIALS AS TOPIC;
COOPERATIVE BEHAVIOR;
DRUG DELIVERY SYSTEMS;
DRUG INDUSTRY;
HUMANS;
PEPTIDES;
PHARMACEUTICAL PREPARATIONS;
PROTEIN ENGINEERING;
PROTEIN STABILITY;
PROTEIN STRUCTURE, SECONDARY;
|
|
EID: 77957954206
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1010-992c Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
